VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement
Updated
Solicitation from the Department of Veterans Affairs, for work in Boise, Idaho. Due Nov 18, 2026, 5:00 PM (UTC-8), 7 days left.
| Solicitation number | 36C26027Q0109 |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 260-Network Contract Office 20 (36C260) |
| Notice type | Solicitation |
| Set-aside | None |
| Trade (NAICS) | In-Vitro Diagnostic Substance Manufacturing (325413) |
| Product or service code | Q301 |
| Place of performance | Boise, Idaho |
| Posted | Nov 10, 2026 |
| Response deadline | Nov 18, 2026, 5:00 PM (UTC-8) (7 days left) |
| Add the deadline to | Google Calendar · Apple / Outlook (.ics) |
Bid documents (4)
- Boise Lab - STATEMENT OF WORK - Blood Reagents 254 KB
- Wage Determination 2015-5503 Ada-Boise-Canyon-Gem-Owyhee Cntys ID Rev 30 237 KB
- Request for Quotations 261 KB
- Synopsis 24 KB
Paid members download every document from this page, or buy this bid alone.
Wage rates for this bid
- Service Contract Act wage determination 2015-5503 Idaho Counties of Ada, Boise, Canyon, Gem and Owyhee
All Idaho prevailing wage rates.
Description
Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care.
5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon the Government's needs and discretion.
Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN.
The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products.
The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety.
Contracting contact
- Andrew O'Neal · andrew.o'[email protected]
As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.
Is your business small enough?
For NAICS 325413, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.
Companies that win this kind of work
Federal contractors paid for in-vitro diagnostic substance manufacturing work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.
- Cepheid $34.9 million in this trade
- Biomerieux Inc $34.6 million in this trade
- Roche Diagnostics Corporation $20.9 million in this trade
- Abbott Laboratories Inc. $4.8 million in this trade
- Quest Diagnostics Incorporated $4.4 million in this trade
About the buyer
The Department of Veterans Affairs awarded $83.7 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.
In-Vitro Diagnostic Substance Manufacturing contracts right now
There are 20 open government contract opportunities in this trade (NAICS 325413), 10 posted in the last 7 days; 55% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Health Agency (DHA) and National Institutes of Health. Most of the work with a stated place is in Maryland, Texas and Arizona. A notice in this trade gives a median of 15 days from posting to deadline; this one gives 8 days.
All open in-vitro diagnostic substance manufacturing contracts
Coming up in this trade
Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.
Recent awards in this trade
- Alba Bioscience, Inc. $11.0 million · Department of Veterans Affairs · Nov 2, 2026
- Abbott Molecular Inc. $919,866 · Department of Veterans Affairs · Oct 6, 2026
- Werfen USA LLC $345,941 · Department of Veterans Affairs · Oct 1, 2026
- Werfen USA LLC $69,188 · Department of Veterans Affairs · Oct 1, 2026
- Biomerieux Inc $284,026 · Department of Veterans Affairs · Oct 1, 2026
From the award notices agencies publish.